Johnson & Johnson (NYSE:JNJ) is reportedly negotiating with plaintiffs’ lawyers who have opposed its proposed $6.48 billion settlement over claims that its talc-based baby powder and other products cause cancer.
What Happened: Per a Reuters report, the New Brunswick, New Jersey-based company aims to resolve the remaining holdouts as it seeks to finalize the deal through the bankruptcy of a subsidiary following setbacks in federal courts.
Johnson & Johnson has temporarily paused the voting process to gather more votes from plaintiffs who have been resistant.
Also Read: JohnsonA & Johnson Strikes $1.7B Deal To Acquire Heart-Tech Innovator V-Wave.
“We have agreed to a short extension of the certification timeline,” said Erik Haas, ...
